Page last updated: 2024-08-25

magnoflorine and Osteosarcoma

magnoflorine has been researched along with Osteosarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Pei, Y; Qiu, E; Shang, G; Wang, W; Wang, Y; Zhang, X1

Other Studies

1 other study(ies) available for magnoflorine and Osteosarcoma

ArticleYear
Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p/HMGB1/NF-κB pathway.
    Life sciences, 2020, Sep-01, Volume: 256

    Topics: Aporphines; Cell Line, Tumor; Cell Proliferation; Cisplatin; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; HMGB1 Protein; Humans; MicroRNAs; Neoplasm Invasiveness; NF-kappa B; Osteosarcoma; Phenotype; Signal Transduction; Up-Regulation

2020
chemdatabank.com